← Back to Clinical Trials
Recruiting NCT05755230

NCT05755230 Prospective Cohort of Perioperative Results

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05755230
Status Recruiting
Phase
Sponsor COPAL - My Journey
Condition Perioperative/Postoperative Complications
Study Type OBSERVATIONAL
Enrollment 50,000 participants
Start Date 2023-01-01
Primary Completion 2043-01-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50,000 participants in total. It began in 2023-01-01 with a primary completion date of 2043-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Perioperative online register of the care process and outcomes. Observational prospective cohort.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing surgery Exclusion Criteria: * None

Frequently Asked Questions

Who can join the NCT05755230 clinical trial?

This trial is open to participants of all sexes, studying Perioperative/Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05755230 currently recruiting?

Yes, NCT05755230 is actively recruiting participants. Visit ClinicalTrials.gov or contact COPAL - My Journey to inquire about joining.

Where is the NCT05755230 trial being conducted?

This trial is being conducted at Buenos Aires, Argentina.

Who is sponsoring the NCT05755230 clinical trial?

NCT05755230 is sponsored by COPAL - My Journey. The trial plans to enroll 50,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology